| Suter, Melissa J |
Massachusetts General Hospital
United States |
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy |
5R01CA255326-04 |
|
Guillermo Marquez, Ph.D. |
| Spiegel, Brennan |
Cedars-Sinai Medical Center
United States |
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
5R01CA252211-05 |
|
Rachel Altshuler, Ph.D. |
| Buszczak, Michael |
Ut Southwestern Medical Center
United States |
Developing ribosome biogenesis inhibitors for the prevention of cancer |
5UG3CA290312-02 |
|
Kajal Biswas, Ph.D. |
| Groninger, J. Hunter |
Medstar Health Research Institute
United States |
Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing |
1R21CA299799-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-04 |
|
Rachel Altshuler, Ph.D. |
| Vijayvergia, Namrata |
Research Inst Of Fox Chase Can Ctr
United States |
Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study |
1R21CA292276-01A1 |
|
Rachel Altshuler, Ph.D. |
| Eastham, James A |
Sloan-Kettering Inst Can Research
United States |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
5U01CA266535-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Semmes, Oliver John |
Old Dominion University
United States |
Virginia-UCLA-Toronto Biomarker Characterization Center |
5U2CCA271894-05 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Rosenbluth, Jennifer M. |
University Of California, San Francisco
United States |
In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer |
4R01CA281361-04 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Staff, Nathan P |
Mayo Clinic Rochester
United States |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity |
5R01CA275870-04 |
PAR-21-329 (R01 Clinical Trial Optional) |
Rachel Altshuler, Ph.D. |
